The 5th Annual Cell-Based Assays conference
novel advances in assay development to improve correlation to clinical data
Our 5th annual Cell Based Assays event includes a BRAND NEW pre-conference workshop; “Stem Cells in Drug Discovery”. This is an excellent opportunity for delegates to get to grips with increasing the role of stem cells in drug discovery and understand how to optimise their use in assays and screening to determine efficacy and levels of toxicity.
Cell Based Assays is the only event to address novel imaging technologies; don’t miss out on this opportunity to hear successful case studies from industry figureheads on optimising florescent protein tagging as well as label free technologies to make sure your organisation is not left behind in this fast moving industry!
Highlights of Cell-Based Assays 2010
A case study led agenda focusing on:
Homepage speakers
Homepage speakers
Carsten Grötzinger
Group Leader
Charité - Universitätsmedizin Berlin, Germany
|
Daniel Zicha
Head of Light Microscopy
Cancer Research UK London Research Institute, United Kingdom
|
Fabio Gasparri
Research Scientist
Nerviano Medical Sciences srl, Italy
|
Laurence Lafanechère
Researcher and Scientific Director
Centre for Bio-Active Molecule Screening (CMBA, CEA-Grenoble), CNRS, France
|
Peter Horvath
Image Processing Scientist
Light Microscopy Centre, ETH Zurich, Switzerland
|
Conference Sponsors
Sponsors & Exhibitors
Promotional Participants
Media Partners
Co-located events
Who should attend Cell-Based Assays 2010?
Heads of Department, Directors, Managers, Team Leaders, Researchers and Scientists from:
• Screening
• Pharmacology
• Lead discovery technologies
• Molecular and cellular biology
• Biological technologies
• Lead generation and optimisation
• High content analysis
• Target identification and validation
• Target discovery
• In vitro
• Compound profiling
• Assay development
• Biology
Evening Seminar, Tuesday 8 June 2010
Outsourcing in Drug Discovery
• Selecting what to outsource
• Weighing up the benefits
• Management of outsourcing projects
• Advantages and disadvantages of partnerships in drug discovery
• How can European companies attract business and maintain a competitive edge against cheaper Asian alternatives?
• Overcoming issues with intellectual property
Iain Comley, Associate Director, R&D, Science and Technology Alliances, AstraZeneca, UK
Poll
Which target is the most challenging to set up an assay for?
Please select an answer
Reviews
"Very interesting event showing also diversity of interests, technologies, and approaches used for cell based assays"
"Bringing together experts in a very relaxed atmosphere"
